Lung Bioavailability With Continuous or Discontinuous Nebulization

N/ACompletedNCT01913184

Cliniques universitaires Saint-Luc- Université Catholique de Louvain6 enrolled

Overview

To compare the continuous and sicontinuous delivery of drug with AKITA.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

AKITADEVICE

Sex: MALEMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * no lung disease * no allergy Exclusion Criteria: * smoker

Cliniques universitaires Saint-Luc

Brussels, Belgium

Lung bioavailability by urinary monitoring

Time frame: 24h after the nebulization

Duration of the nebulization

Time frame: After the nebulization

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.